Table 1 Characteristics of the 7 glioblastoma patients: Tumor localization in the patient; study arm A or B; treatment technique; skin high dose area (surface dose > 70% of the prescribed dose within or up to 6 mm below the skin on a scalp area are of > 50 cm2); delivered dose; number of fractions with set up cone beam CT; temozolomide
Tumor localization in the patient identified by the respective row of table | Study arm A or B | Treatment technique | Skin high dose area | Delivered dose | Number of fractions with set up cone beam CT | Temozolomide |
|---|---|---|---|---|---|---|
Left parietal | A | Non-coplanar IMRT | 2.4 cm3/ 12 cm2 | 30 × 2 Gy | 28 | 75 mg/m2 |
Right frontotemporal | A | Non-coplanar IMRT | 4.4 cm3/ 22 cm2 | 30 × 2 Gy | 28 | 75 mg/m2 |
Right parietal | B | Non-coplanar IMRT | 18 cm3/ 90 cm2 | 15 × 2.67 Gy | 5 | 75 mg/m2 |
Left frontal | A | Non-coplanar arcs | 12 cm3/ 60 cm2 | 30 × 2 Gy | 23 | 75 mg/m2 |
Right frontal | B | Non-coplanar arcs | 0.4 cm3/ 2 cm2 | 15 × 2.67 Gy | 15 | 75 mg/m2 |
Right parietal | A | Non-coplanar IMRT | 37,1cm3/ 185.5 cm2 | 30 × 2 Gy | 30 | 75 mg/m2 |
Right frontal | A | Non-coplanar IMRT | 7.1cm3/ 35.5 cm2 | 30 × 2 Gy | 30 | 75 mg/m2 |